DBV Technologies (DBVT) Cash & Equivalents (2015 - 2026)

DBV Technologies (DBVT) posted quarterly Cash & Equivalents of $174.9 million for Q2 2026, up 69.47% year-on-year from $103.2 million in Q2 2025, and down 23.69% on a QoQ basis from $229.2 million in Q1 2026.

DBV Technologies (DBVT) Cash & Equivalents (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Cash & Equivalents for 12 consecutive years, with $174.9 million the latest figure, recorded in Q2 2026.

  • Quarterly Cash & Equivalents rose 69.47% year-over-year to $174.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $174.9 million (up 69.47% YoY) and the FY2025 annual result came in at $194.2 million, up 498.35% from the prior year.
  • Cash & Equivalents fell to $174.9 million in Q2 2026 per DBVT's latest filing, from $229.2 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for DBVT reached as high as $248.0 million in Q2 2022 and fell as low as $13.0 million in Q1 2025.
  • A 5-year average of $135.1 million and a median of $145.3 million in 2023 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2025 — Cash & Equivalents sank 87.23% — and 2026, when it surged 1668.25%.
  • Year by year, Cash & Equivalents stood at $209.2 million in 2022, then sank by 32.42% to $141.4 million in 2023, then slumped by 77.04% to $32.5 million in 2024, then surged by 498.35% to $194.2 million in 2025, then retreated by 9.94% to $174.9 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $174.9 million, $229.2 million, and $194.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 82.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 440.94 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - 174.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 174.90 Mn
Mar 31, 2026 229.20 Mn
Dec 31, 2025 194.20 Mn
Sep 30, 2025 69.84 Mn
Jun 30, 2025 103.21 Mn
Mar 31, 2025 12.96 Mn
Dec 31, 2024 32.46 Mn
Sep 30, 2024 46.44 Mn
Jun 30, 2024 66.21 Mn
Mar 31, 2024 101.53 Mn
Dec 31, 2023 141.37 Mn
Sep 30, 2023 149.14 Mn
Jun 30, 2023 173.96 Mn
Mar 31, 2023 192.29 Mn
Dec 31, 2022 209.19 Mn
Sep 30, 2022 212.67 Mn
Jun 30, 2022 247.97 Mn
Mar 31, 2022 74.11 Mn
Dec 31, 2021 77.30 Mn
Sep 30, 2021 98.20 Mn